Taro Pharmaceutical Industries (TARO)
(Delayed Data from NYSE)
$42.23 USD
-0.03 (-0.07%)
Updated Apr 23, 2024 04:00 PM ET
After-Market: $42.24 +0.01 (0.02%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For TARO
-
Taro: Fiscal Q3 Earnings Snapshot
-
Taro to Release Third Quarter Results on January 25, 2024
-
Taro Pharmaceutical (TARO) Tops Q2 Earnings Estimates
-
Taro: Fiscal Q2 Earnings Snapshot
-
Taro to Release Second Quarter Results on October 26, 2023
-
Taro: Fiscal Q1 Earnings Snapshot
-
Taro to Release First Quarter Results on July 26, 2023
-
Taro Annual Report on Form 20-F Available For Fiscal Year Ended March 31, 2023
-
Taro: Fiscal Q4 Earnings Snapshot
-
Taro Pharmaceutical (TARO) Lags Q3 Earnings and Revenue Estimates
-
Taro: Fiscal Q3 Earnings Snapshot
-
Taro to Release Third Quarter Results on January 24, 2023
-
Taro Pharmaceutical (TARO) Reports Q2 Loss, Misses Revenue Estimates
-
Taro: Fiscal Q2 Earnings Snapshot
-
Taro to Release Second Quarter Results on October 27, 2022
-
Taro Pharmaceutical (TARO) Lags Q1 Earnings Estimates
-
Taro: Fiscal Q1 Earnings Snapshot
-
Taro Pharmaceutical (TARO) Q3 Earnings and Revenues Miss Estimates
-
Taro Pharmaceutical (TARO) Earnings Expected to Grow: Should You Buy?
-
Taro Pharmaceutical (TARO) Lags Q2 Earnings and Revenue Estimates
-
Earnings Preview: Taro Pharmaceutical (TARO) Q2 Earnings Expected to Decline
-
Taro Pharmaceutical (TARO) Q1 Earnings and Revenues Beat Estimates
-
Taro Pharmaceutical (TARO) Q2 Earnings and Revenues Top Estimates
-
Taro Pharmaceutical (TARO) Misses Q1 Earnings and Revenue Estimates
-
Taro Pharmaceutical (TARO) Misses Q4 Earnings Estimates